Obchod CVAC

CureVac N.V.

-

00:00:00

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.
Více informací...

CVAC
Obchodní specifikace

Číslice

3

Bod

0.001

Spread

floating

Velikost smlouvy

1

Objem min.

1

Maximální objem

10,000

Krok svazku

1

Výměna dlouhých (bodů)

-2.270

Swap Short (body)

-1.310
K dispozici na
MT5, TV, cTrader
Poslední aktualizace v 3 prosince, 21:09 GMT+3
*Zdroj dat: MT5 Server Prime Account Pricing

CVAC
Ekonomický kalendář

Nebyly nalezeny žádné údaje

1D Změna

2.374%

Proč BlackBull Markets?

26k+

Obchodovatelná aktiva

1:500

Pákový efekt až do

Regulované stránky

Víceregulátorové

24/7

Zákaznická podpora

$0

Žádný minimální vklad

Kalkulačka marže

Calculation Results

Current Price

2.82

Required Margin

Converted Currency

Required Margin

Account Base Currency

Kalkulačka zisku/ztráty

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Kalkulačka swapů

Calculation Results

2.82

Obchodní příležitosti

Nebyly nalezeny žádné údaje
Join Now